Although I have highlighted some of the valuable resources the ACR provides to its members, I want to stress that there is much more that goes on behind the scenes to impact the future of rheumatology and patients’ access to quality care. Beyond the various member communications meant to keep you informed of important developments in such areas as rheumatology education, treatment, research and legislation, the ACR and its volunteers work continually on the advocacy front both at the federal and state levels. We also have a very active voice in regulations surrounding the use of biosimilars. The ACR exists to actively support your profession, and I am excited to see continued progress in the coming year.
You Might Also Like
Explore This IssueFebruary 2017
Also By This Author
We want and need practicing rheumatologists and their staff to get actively involved in the ACR and ARHP. You can give us valuable feedback on our resources and advocacy efforts; or better still, if you are passionate about our mission, join us as a volunteer. The ACR’s volunteer nominations process opens on March 1, 2017.
The ACR is committed to Advancing Rheumatology!, and that begins with supporting you and your staff in the important work of caring for patients. So call, write or email us today, and let us know how we can help you and your practice thrive.
Sharad Lakhanpal, MBBS, MD, is in private practice at Rheumatology Associates and a clinical professor of internal medicine at the University of Texas Southwestern Medical School, both in Dallas, where he has lived and worked since 1986. He is also the 80th president of the ACR (2016–17).